医学
溶栓
改良兰金量表
优势比
冲程(发动机)
子群分析
随机对照试验
随机化
内科学
临床终点
心脏病学
逻辑回归
急性中风
缺血性中风
外科
麻醉
置信区间
组织纤溶酶原激活剂
心肌梗塞
缺血
机械工程
工程类
作者
Qiwen Deng,Lei Zhang,Yukai Liu,Feng Zhou,Zhenhua Yuan,Xixi Wang,Jie Gao,Pengfei Yang,Yongwei Zhang,Pengfei Xing,Zifu Li,Hong Bo,Hongxing Han,Huaizhang Shi,Hongchao Shi,Jianmin Liu
出处
期刊:Cerebrovascular Diseases
[S. Karger AG]
日期:2023-08-18
卷期号:53 (2): 176-183
摘要
<b><i>Introduction:</i></b> Whether time window affects the intravenous thrombolysis (IVT) effect before endovascular thrombectomy (EVT) is uncertain. We aimed to investigate the effect of different time windows (0–3 h and >3–4.5 h from stroke onset to randomization) on clinical outcomes of EVT with or without IVT in a subgroup analysis of DIRECT-MT. <b><i>Methods:</i></b> The primary outcome was the 90-day modified Rankin Scale (mRS) according to time window. Logistic regression models were used to analyze the effect of different treatments (EVT with or without IVT) on outcomes within 0–3 h or >3–4.5 h. <b><i>Results:</i></b> Among 656 patients who were included in the analysis, 282 (43.0%) were randomized within >3–4.5 h after stroke onset (125 without IVT and 157 with IVT), and 374 (57.0%) were randomized within 0–3 h (202 without IVT and 172 with IVT). We noted no significant difference in the thrombectomy-alone effect between the time window subgroups according to 90-day ordinal mRS (adjusted common odds ratio [acOR] in patients within 0–3 h: 1.06 [95% CI: 0.73–1.52], acOR in patients within >3–4.5 h: 1.19 [95% CI: 0.78–1.82]) and 90-day functional independence. Thrombectomy alone resulted in an increased proportion of patients with 90-day mRS 0–3 treated within >3–4.5 h (62.90 vs. 48.72%) but not within 0–3 h (65.84 vs. 63.95%). However, there was no interaction effect regarding all outcomes after the Bonferroni correction. <b><i>Conclusions:</i></b> Our results did not support thrombectomy-alone administration within 3–4.5 h in patients with acute ischemic stroke from large-vessel occlusion in the subgroup analysis of DIRECT-MT.
科研通智能强力驱动
Strongly Powered by AbleSci AI